Mosaic Trial for Stem Cell Transplant Recipients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical trial is to learn if using an intervention website (Mosaic) improves selected patient-reported outcomes in adult blood cancer patients undergoing allogeneic or autologous stem cell transplant, compared to using an educational website (control group). Patients will be recruited prior to their scheduled transplant, then randomized to use one of these two study websites throughout the study. They will complete five assessments during the study: one before transplant (baseline) and four after transplant (2, 4, 6, and 8 month follow-ups). The main questions this trial aims to answer are: 1. Compared to patients using the control group website, do patients using the intervention website report greater improvements in general psychological distress, cancer treatment-related distress, physical symptoms, and health-related quality of life? 2. Are these benefits at least partially explained by improvements in perceived preparedness, self-efficacy, and approach coping and/or reductions in avoidant coping and perceived stress? 3. Do some patients benefit more from using the intervention website than others? Specifically, we will examine whether patients' primary language (English/Spanish) and their initial psychological distress are related to the benefit they get from using the intervention website. We will also explore effects of sex, race, ethnicity, and transplant type.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie raka krwi potwierdzone w dokumentacji medycznej
- •Planowany przeszczep szpiku (od dawcy lub własnych komórek)
- •Wiek 18 lat lub więcej
- •Biegła znajomość języka angielskiego lub hiszpańskiego
- •Zainteresowanie uczestnictwem w badaniu online
- •Umiejętność zrozumienia i podpisania zgody na uczestnictwo
✗ Disqualifies
- •Uczestnictwo w innym programie wsparcia psychicznego lub zdrowotnego
- •Planowana seria dwóch przeszczepiów (uczestnictwo dopiero w drugim)
- •Poważne problemy z pamięcią lub zrozumieniem, uniemożliwiające świadomą zgodę
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (3)
Georgetown University School of Medicine
Washington D.C., United States
Northwestern University Feinberg School of Medicine
Chicago, United States
Hackensack Meridian Health
Nutley, United States
Trial contact
Christine Rini, PhD
Sonia Zavala
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.